Edenbridge Pharmaceuticals is Pharmaceuticals in United States that focus on Zidovudine syrup business. Founded in 2008. They cover business area such as provider, developer, prescription pharmaceutical product, marketing prescription, Methenamine Mandelate tablet, opium tincture, oral solution, Zidovudine capsule, Zidovudine syrup, its goal, limited source, high-quality, affordable, and accessible alternative.
2008
( 16 years old in 2024 )
Zidovudine Syrup
-
169 Lackawanna Avenue
Suite 110
Parsippany, NJ 07054
United States
Private
providerdeveloperprescription pharmaceutical productmarketing prescriptionMethenamine Mandelate tabletopium tinctureoral solutionZidovudine capsuleZidovudine syrupits goallimited sourcehigh-quality, affordable, and accessible alternative
* We use standard office opening hours in near Edenbridge Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Edenbridge Pharmaceuticals is Pharmaceuticals business from United States that founded in 2008 (16 years old in 2024), Edenbridge Pharmaceuticals business is focusing on Zidovudine Syrup.
Edenbridge Pharmaceuticals headquarter office and corporate office address is located in 169 Lackawanna Avenue Suite 110 Parsippany, NJ 07054 United States.
Edenbridge Pharmaceuticals was founded in United States.
In 2024, Edenbridge Pharmaceuticals is currently focus on Zidovudine syrup sector.
Above is snippet of Google Trends for "Zidovudine syrup" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Edenbridge Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.